In addition to the acquisition of self-renewal ability, we observed that activation of EMT by TrkC-mediated upregulation of EMT-TFs is sufficient for essential for protecting HCC cells from therapeutic agents. This evidence concerns the gene NTRK3 and hepatocellular carcinoma.